Article
Development of new fusion proteins for visualizing amyloid-β oligomers in vivo
16 Mar 2016
Abstract excerpt
The intracellular accumulation of amyloid-β (Aβ) oligomers critically contributes to disease progression in Alzheimer's disease (AD) and can be the potential target of AD therapy. Direct observation of molecular dynamics of Aβ oligomers in vivo is key for drug discovery research, however, it has been challenging because Aβ aggregation inhibits the fluorescence from fusion proteins. Here, we developed Aβ1-42-GFP...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
